Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Indian J Pathol Microbiol ; 66(3): 618-620, 2023.
Article in English | MEDLINE | ID: mdl-37530354

ABSTRACT

Dual pathology in the pituitary gland is a unique phenomenon. Coexistence of a pituitary adenoma with primary hypophysitis has been reported rarely with very few cases in the literature. Among the primary hypophysitis, primary granulomatous subtype has been proposed to be idiopathic and autoimmune in nature. Plurihormonal pituitary adenomas produce hormones of more than one different pituitary cell lineage. Pituitary adenoma with a single hormonal content has been documented with concurrent primary granulomatous hypophysitis. The present case describes the unique coexistence of a plurihormonal adenoma showing somatotroph, lactotroph, and corticotroph lineage with primary granulomatous inflammation in the sellar region in a 36-year-old woman.


Subject(s)
Adenoma , Hypophysitis , Pituitary Neoplasms , Female , Humans , Adult , Pituitary Neoplasms/complications , Pituitary Neoplasms/diagnosis , Pituitary Neoplasms/pathology , Hypophysitis/complications , Hypophysitis/diagnosis , Pituitary Gland/pathology , Adenoma/complications , Adenoma/diagnosis , Adenoma/pathology , Diagnosis, Differential
2.
Indian J Pathol Microbiol ; 66(2): 278-285, 2023.
Article in English | MEDLINE | ID: mdl-37077068

ABSTRACT

Background: Peripheral neuroblastic tumors arise from the sympathoadrenal lineage of the neural crest. They have been classified according to the International Neuroblastoma Pathology Committee (INPC) into Four categories according to International Neuroblastoma Pathology Committee (INPC): a) Neuroblastoma (NB) b) Ganglioneuroblastoma (GNB), nodular c) Ganglioneuroblastoma, intermixed, and d) Ganglioneuroma (GN). Because of the rarity of extra-adrenal peripheral neuroblastic tumors, limited information is available regarding the chemotherapy of NB and GNB. A few case reports or case series with a small number of patients have been documented in the literature. Aim: To describe the clinicopathological characteristics of extra-adrenal peripheral neuroblastic tumors. Materials and. Methods: Clinical, histopathological, and immunohistochemistry (IHC) findings of 18 cases were retrieved. Immunohistochemistry at the time of diagnosis was performed using Ventana Benchmark XT. The mean value was calculated using the Microsoft Office Excel 2019 software. Results: The posterior mediastinum was the most commonly affected extra-adrenal site in our study. Neuroblastoma consisted of eight cases (six in children, two in adults), of which four cases were poorly differentiated and the other four cases were differentiating. Two cases had favorable histology. The bone marrow and cervical lymph node metastasis were documented. Of the four GNB cases, one patient developed bone metastasis. All patients of NB and GNB received combination chemotherapy. One out of six GN patients presented with a large retroperitoneal mass encasing the aorta and renal vessels, mimicking a sarcoma. Conclusion: Extra-adrenal peripheral neuroblastic tumors do not pose any diagnostic issue in adequate tissue sampling. In limited material, immunohistochemistry is needed. The chemotherapy regimen has not been standardized due to rarity. Further molecular testing and targeted therapy may be of help in the future.


Subject(s)
Ganglioneuroblastoma , Ganglioneuroma , Neuroblastoma , Child , Humans , Ganglioneuroblastoma/diagnosis , Ganglioneuroblastoma/pathology , Neuroblastoma/diagnosis , Immunohistochemistry , Ganglioneuroma/diagnosis
3.
Acta Cytol ; 67(4): 333-345, 2023.
Article in English | MEDLINE | ID: mdl-36580900

ABSTRACT

INTRODUCTION: Pulmonary spindle cell and mesenchymal lesions are paradox for pathologists due to their rarity, overlapping morphology, and differentials ranging from benign to malignant lesions, and correct diagnosis is essential due to major treatment implications. This study highlights the role of fine-needle aspiration cytology, clot core biopsy, and immunohistochemistry in diagnosis of spindle cell lesions in lung, thus playing a key role in patient management. METHODS: It is a retrospective study of lung FNA with predominantly spindle and mesenchymal cells from 2015-2020 which were classified cytomorphologically into spindle, epithelioid, small round cell, and biphasic, and IHC panels are applied accordingly. FNA from mediastinum and chest wall was excluded. RESULTS: 60 cases of lung FNA with spindle and mesenchymal cells were identified and included 6 benign and 54 malignancies which included 24 primary pulmonary malignancies and 30 metastases. Most common primary malignancy was sarcomatoid carcinoma, and most common metastasis was malignant peripheral nerve sheath tumour. FNA was paucicellular in 7 cases and was reported as benign in 7 cases and malignant in 46 cases. There were two false-negative cases. One case of pulmonary blastoma was reported as inflammatory pseudotumour on cytology, and other case of chondrosarcoma was reported as chondroid tumour. Sensitivity and specificity of FNA in distinguishing benign lesions and malignancies were 93.8% and 100%, respectively. CONCLUSION: FNA along with clot core biopsy/cell block and IHC plays a pivotal role in the subsequent pathway taken for diagnostic or therapeutic management of these patients without the need for second sampling or trucut biopsies in a low resource setting.


Subject(s)
Carcinoma , Neoplasms, Connective and Soft Tissue , Humans , Biopsy, Fine-Needle , Retrospective Studies , Biopsy, Large-Core Needle , Carcinoma/pathology , Sensitivity and Specificity , Lung/pathology
4.
Indian J Pathol Microbiol ; 65(2): 452-454, 2022.
Article in English | MEDLINE | ID: mdl-35435393

ABSTRACT

Aneurysmal bone cyst (ABC) is a benign expansile cystic lesion that can affect any bone of the skeleton, especially the femur, tibia, and humerus. Lesions with histologic features of an ABC can be originated within soft tissue in exceedingly rare cases. Extra-skeletal ABC may mimic a variety of benign and malignant lesions and can be confused with other common or rare giant cell-rich tumors of soft tissue. Clinical, radiological and histologic correlation are crucial in reaching the correct diagnosis. Here we report a case of an extra-skeletal ABC arising in left hemithorax in a 13-year-old girl and discuss the common differential diagnosis of this rare entity.


Subject(s)
Bone Cysts, Aneurysmal , Giant Cell Tumors , Adolescent , Bone Cysts, Aneurysmal/diagnostic imaging , Bone Cysts, Aneurysmal/surgery , Diagnosis, Differential , Female , Femur/diagnostic imaging , Femur/pathology , Giant Cell Tumors/diagnosis , Humans , Tibia/diagnostic imaging , Tibia/pathology
5.
Indian J Pathol Microbiol ; 65(1): 181-183, 2022.
Article in English | MEDLINE | ID: mdl-35074991

ABSTRACT

Tumor-induced osteomalacia is a paraneoplastic syndrome resulting in renal phosphate wasting and decreased bone mineralization. Phosphaturic mesenchymal tumors represent a rare etiology of tumor-induced osteomalacia. They are exceptionally rare, probably accounting for < 0.01% of all soft tissue tumors. Most PMTs present as small inapparent lesions that require very careful clinical examination and radionucleotide scan for localization. Here we describe a case in a 65 years old woman with recurrent multiple bone fractures and subsequent detection of a tumor involving right femur and adjacent soft tissue, low phosphate level and elevated serum Fibroblast growth factor-23 (FGF-23).


Subject(s)
Mesoderm/pathology , Phosphates/blood , Soft Tissue Neoplasms/diagnostic imaging , Aged , Female , Femur/diagnostic imaging , Femur/pathology , Fibroblast Growth Factors/blood , Histological Techniques , Humans , Magnetic Resonance Imaging , Mesoderm/surgery , Positron-Emission Tomography , Soft Tissue Neoplasms/surgery
7.
Diagn Cytopathol ; 49(8): 948-958, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33973738

ABSTRACT

BACKGROUND: Serous effusions (SE) in leukemic patients can be due to infections, therapy, volume overload, lymphatic obstruction or malignancy having implications on treatment and mortality. The objective of the present study is to highlight the spectrum of cytomorphology, immunophenotype, and cytogenetics in leukemic serous effusions (LSE). MATERIALS: Present study is retrospective and descriptive. We reviewed all the SE, which were reported as suspicious or positive of leukemic infiltration from 2016 to 2019 for cytomorphological features. CSF and effusions involved by lymphomas were excluded. Cyto-diagnosis was compared with primary proven diagnosis (by ancillary techniques) and disconcordant cases were analyzed. RESULTS: Out of total 9723 effusions, only 0.4% (n = 40) showed leukemic involvement and included nine cases of AML, three of B-ALL, 13 T-ALL, 2 MPAL, 6 CML, 5CLL, one each of chronic myelomonocytic leukemia and AML with myelodysplasia. The most common site of involvement was the pleural cavity (n = 30), followed by the peritoneal cavity (n = 7) and the pericardial cavity (n = 3). T -ALL (41.9%) was the most common leukemia involving pleural fluid followed by AML (23.3%). CML (42.8%) was the most common leukemia involving the ascitic fluid followed by B-ALL (28.6%). Accurate diagnosis was given on cytomorphology in 72.5% (29/40) cases and 15.0% (6/40) were reported as non-Hodgkin lymphoma. CONCLUSION: Cytology is an effective tool available to make a diagnosis of LSE. Nuclear indentations in large atypical cells and cells with eosinophilic granular cytoplasm with sparse or abundant eosinophils in the background are an important clue in favor of leukemia over lymphoma.


Subject(s)
Cytogenetic Analysis , Exudates and Transudates , Immunophenotyping , Leukemia , Lymphoma , Adolescent , Adult , Aged , Aged, 80 and over , Ascitic Fluid/immunology , Ascitic Fluid/pathology , Child , Child, Preschool , Cytodiagnosis/methods , Cytological Techniques/methods , Diagnosis, Differential , Exudates and Transudates/cytology , Exudates and Transudates/immunology , Female , Flow Cytometry/methods , Humans , Infant , Leukemia/diagnosis , Leukemia/pathology , Lymphoma/diagnosis , Lymphoma/pathology , Lymphoma, Non-Hodgkin/diagnosis , Lymphoma, Non-Hodgkin/pathology , Male , Middle Aged , Pericardial Effusion/genetics , Pericardial Effusion/immunology , Pericardial Effusion/pathology , Pleural Effusion/genetics , Pleural Effusion/immunology , Pleural Effusion/pathology , Retrospective Studies
8.
Indian J Pathol Microbiol ; 64(2): 316-322, 2021.
Article in English | MEDLINE | ID: mdl-33851626

ABSTRACT

BACKGROUND: Follicular dendritic cell sarcomas (FDCSs) and histiocytic sarcomas (HSs) are exceedingly rare tumors. Most of the data on those entities are based on case reports or small case series. The natural history and response to different treatment modalities have not been well established. AIMS: To analyze the clinicopathologic features, immunophenotypic profile, treatment responses and to add to the existing data on FDCS and HS. STUDY DESIGN: Retrospective descriptive study. MATERIALS AND METHOD: The study was conducted at the department of Oncopathology at a tertiary care cancer hospital in India, retrospectively within the time period of four years (2016-2019). Total eight (8) cases were diagnosed: four cases of FDCS and four cases of HS involving nodal and extra-nodal sites. Clinical, histopathological, immunohistochemistry (IHC) and therapeutic data of the eight cases were retrieved and analyzed. STATISTICS: Descriptive statistics. RESULT: Among the four patients of FDCS, two had nodal and two had extra-nodal disease. Mean tumor size was 6 cm. Tumor cells expressed CD23, CD21, CD45, CD68 and S100. One patient received adjuvant chemotherapy (Gemcitabine and Docetaxel). Median survival was 36 months. None of them developed distant metastasis. Two of the patients having HS, developed bone metastasis. Median survival was 8.5 months. CD68 was consistently expressed in all cases of HS. Other applied IHC markers were negative in all the eight cases. CONCLUSION: FDCS and HS are under-recognized and easily prone to a wrong diagnosis. Therefore, considering these rare entities in differential diagnoses and inclusion of proper IHC biomarkers are necessary to avoid potential misdiagnosis.


Subject(s)
Dendritic Cell Sarcoma, Follicular/diagnosis , Dendritic Cell Sarcoma, Follicular/pathology , Dendritic Cells, Follicular/pathology , Histiocytic Sarcoma/diagnosis , Histiocytic Sarcoma/pathology , Lymph Nodes/pathology , Adult , Antimetabolites, Antineoplastic/therapeutic use , Chemotherapy, Adjuvant , Dendritic Cell Sarcoma, Follicular/therapy , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Docetaxel/therapeutic use , Female , Histiocytic Sarcoma/therapy , Humans , Immunohistochemistry/methods , Male , Middle Aged , Retrospective Studies , Gemcitabine
9.
Acta Cytol ; 65(2): 175-185, 2021.
Article in English | MEDLINE | ID: mdl-33316798

ABSTRACT

INTRODUCTION: Cytology provides crucial window for early diagnosis of malignant mesothelioma (MM) since it is often the first and easily available material for evaluation, resulting in early treatment. Still, its role is overlooked in the current treatment guidelines. The aim of this study is to determine the sensitivity of cytomorphology and role of subsequent ancillary techniques in diagnosing MM. METHODS: This is a 5-year retrospective analysis of MM in the tertiary oncology center to determine sensitivity of cytomorphology and subsequent role of immunohistochemistry (IHC) in final diagnosis of MM according to the guidelines for cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma (GCDMM) laid by International Mesothelioma Interest Group. Cytomorphology and immunocytochemistry from effusions and fine needle aspirations were analyzed. RESULTS: Sixty-two of 128 cases of MM had cytology and cytomorphological criteria described in GCDMM were fulfilled in 61.3% cases. Architectural atypia was useful in identifying cases with low cytological atypia. Overall sensitivity of cytomorphology was 73.01%. Sensitivity of effusion cytology was 77.8%. Subsequent IHC on cell blocks revealed the sensitivity as 100% for mesothelin, calretinin, and cytokeratin 5/6; 87.5% for thrombomodulin; and 50% for WT1, while CEA and TTF1 showed 100% specificity. Treatment was given based on final diagnosis of MM given after IHC on cytology material in only 25.8% cases. However, it was possible in additional 35.5% cases. Mean survival was 10 months when diagnosed by cytology, compared to 7 months by histology. CONCLUSIONS: Rather than ignoring the role of cytology in the diagnosis and treatment guidelines for MM, it is important to understand its strengths and limitations. Standardized guidelines in future can play an important role in more streamlined communication between cytopathologist and clinician.


Subject(s)
Early Detection of Cancer/standards , Mesothelioma, Malignant/pathology , Practice Guidelines as Topic/standards , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biopsy/standards , Databases, Factual , Female , Humans , Immunohistochemistry/standards , India , Male , Mesothelioma, Malignant/chemistry , Mesothelioma, Malignant/mortality , Mesothelioma, Malignant/therapy , Middle Aged , Predictive Value of Tests , Prognosis , Reproducibility of Results , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL